Taylor Grant D, Johnson D Brooke, Hogg Deborah C, Cadeddu Jeffrey A
Clinical Center for Minimally Invasive Urologic Cancer Treatment, Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA.
J Urol. 2004 Jul;172(1):382-5. doi: 10.1097/01.ju.0000132358.82641.10.
New laparoscopic partial nephrectomy and tumor ablation techniques are continuously being developed and evaluated in large animal models. However, to our knowledge no reliable renal tumor model exists to evaluate procedure efficacy. We developed and assessed the reliability of a tumor mimic model to serve as a training tool for minimally invasive kidney surgery.
An agarose based model was created using a mixture of 3% agarose, 3% cellulose, 7% glycerol and 0.05% methylene blue. It is liquid when heated, but solidifies after cooling to physiological temperatures. The agar was injected (0.7 cc) into porcine renal parenchyma to make endophytic or completely intraparenchymal lesions. Three-dimensional ultrasound images of the lesions were obtained during initial development to ensure spherical lesions. A group of 20 lesions was initially placed in an ex vivo setting to assess size consistency and define baseline impedance characteristics. An additional 20 tumor mimics each were established in a laparoscopic model in a laparoscopic box trainer and an in vivo laparoscopic model. They were ablated with a temperature based radio frequency generator to assess impedance characteristics but the efficacy of ablation was not assessed. The in vivo model consisted of placing the agar lesion percutaneously under direct laparoscopic vision.
The agarose mixture was easily injected and readily visible on ultrasound as hyperechoic distinct lesions. Lesions had a mean size of 10.8 +/- SD 1.3 mm on ultrasound and 10.9 +/- 1.2 mm grossly. The impedance of normal renal parenchyma and unablated lesions was similar. Mean lesion size in the ex vivo model after radio frequency ablation was 9.8 +/- 2.0 mm on ultrasound, which was similar to the gross mean lesion size of 9.7 +/- 1.0 mm. Similar results were obtained for the in vivo model with a mean size of 10.1 +/- 2.1 and 10.4 +/- 1.5 mm, respectively. The lesions were easily identified grossly as blue solid lesions that replaced renal parenchyma.
The described renal tumor mimic model reproducibly creates ex vivo and in vivo porcine kidney lesions. Lesion size and impedance do not change with the application of radio frequency energy. This model should be a valuable adjunct in the development, assessment and teaching of novel, nephron sparing, minimally invasive surgical techniques.
新型腹腔镜部分肾切除术和肿瘤消融技术不断在大型动物模型中得到开发和评估。然而,据我们所知,尚无可靠的肾肿瘤模型可用于评估手术疗效。我们开发并评估了一种肿瘤模拟模型的可靠性,以作为微创肾脏手术的训练工具。
使用3%琼脂糖、3%纤维素、7%甘油和0.05%亚甲蓝的混合物创建基于琼脂糖的模型。加热时呈液体状态,但冷却至生理温度后会凝固。将琼脂(0.7毫升)注入猪肾实质,形成内生性或完全位于实质内的病变。在初始开发过程中获取病变的三维超声图像,以确保病变呈球形。最初将一组20个病变置于离体环境中,以评估大小一致性并确定基线阻抗特征。另外在腹腔镜箱式训练器中的腹腔镜模型和体内腹腔镜模型中分别建立20个肿瘤模拟物。使用基于温度的射频发生器对它们进行消融,以评估阻抗特征,但未评估消融效果。体内模型包括在直接腹腔镜视野下经皮放置琼脂病变。
琼脂糖混合物易于注射,在超声上作为高回声明显病变易于观察。病变在超声上的平均大小为10.8±标准差1.3毫米,大体上为10.9±1.2毫米。正常肾实质和未消融病变的阻抗相似。射频消融后离体模型中病变在超声上的平均大小为9.8±2.0毫米,与大体平均病变大小9.7±1.0毫米相似。体内模型也得到了类似结果,平均大小分别为10.1±2.1毫米和10.4±1.5毫米。病变在大体上很容易被识别为取代肾实质的蓝色固体病变。
所描述的肾肿瘤模拟模型可重复性地在离体和体内猪肾中创建病变。病变大小和阻抗不会因射频能量的应用而改变。该模型应成为新型保肾微创外科技术开发、评估和教学中的有价值辅助工具。